Abstract
Three-dimensional (3D) printing concept has been successfully employed in regenerative medicine to achieve individualized therapy due to its benefit of a rapid, accurate, and predictable production process. Traditional biocomposites scaffolds (SCF) are primarily utilised for bone tissue engineering; nevertheless, over the last few years, there has already been a dramatic shift in the applications of bioceramic (BCR) SCF. As a direct consequence, this study focused on the structural, degeneration, permeation, and physiological activity of 3D-printed BCR (3DP-B) SCF with various conformations and work systems (macros, micros, and nanos ranges), as well as their impacts on the mechanical, degeneration, porosity, and physiological activities. In addition, 3DP-B SCF are highlighted in this study for potential uses applied from bone tissue engineering (BTE) to bone tumor treatment. The study focused on significant advances in practical 3DP-B SCF that can be utilized for tumor treatment as well as bone tissue regeneration (BTR). Given the difficulties in treating bone tumors, these operational BCR SCF offer a lot of promise in mending bone defects caused by surgery and killing any remaining tumor cells to accomplish bone tumor treatment. Furthermore, a quick assessment of future developments in this subject was presented. The study not only summarizes recent advances in BCR engineering, but it also proposes a new therapeutic strategy focused on the extension of conventional ceramics’ multifunction to a particular diagnosis.
Introduction
Traffic accidents, old age, bone tumors, and other causes of bone tissue abnormalities have serious consequences for one’s healthcare as well as living standards () . Large bone abnormalities usually necessitate intermediation treatment in order to recover. Nonetheless, because autogenous bone transplant or autograft is the “gold standard” graft material, supply is limited. As a result, several studies (; Zhu et al., 2017; ; ) are focusing on developing innovative tissues engineering methodologies for bones tissues regeneration. Scaffold (SCF) are important in bone tissue creation because they provide a three-dimensional (3D) background for cells connection and propagation. Gas frothing (), Thaw (), fibre companionship, particulate/salt leachate (; ), emulsification (), phase isolation, and other traditional manufacturing processes are still unable to regulate the porous texture, architectural design, permeability, or interconnectedness of the SCF, and can therefore explicitly and sufficiently enhance cell progression and tissue redevelopment (). 3D printing (3DP) technique was developed to enterprise and develop SCF with well-ordered chemistries, intended contours, and linked perviousness using computer-aided design (CAD) and computer-aided manufacturing (CAM) to address the limitations of traditional manufacturing techniques (; ; ; ).
A standard scaffold for bone tissue engineering (BTE) should mimic the shape and physiological activities of typical bone tissue in based on its chemical mixtures, rigid hierarchy, and features. Ceramic-based SCF [e.g., Ca-salts-ceramics, Ca-Si (CS) ceramics, and bioactive-glasses (BGs)] are drawing considerable interest to be used in BTE due to their resemblance to indigenous bone chemical compositions, bio—compatibility, wettability, biological activities, osteoinduction, and printability (). Bioceramic (BCR) frameworks with such a hierarchical system that comprises macroscopic, microscopic, and nanoscale structures have also been created. SCF have indeed been intended with various macrostructures (e.g., pore size, permeability, and pore connectivity) to enable tissue expanding and appropriate transportation of nutrients, oxygen, waste, and growth factors, and to also encourage effective tissue regeneration cell development from the fringes to the interior of the SCF(). SCF with submicron and nanoscale structures have more contact area and ruggedness, which encourages osteoblast adhesion to the scaffold surfaces ().
Few studies of 3D-printed ceramics SCF about bones tissues engineering have been published (), summarizing just 3DP technologies and various types of ceramic-SCF. The goal of current review, on the other hand, is to sketch out the development trend of 3DP-B SCF for applications ranges from bones tissues regeneration to bone tumor treatment. The prior step was to demonstrate 3DP-B SCF with various configurations and structural organization topologies (macros-, micros-, and nanos-scales). Conventionally, 3DP-B SCF were manufactured and primarily used to regenerate bone tissue. This study, on the other hand, emphases on current progresses in functional 3DP-B SCF that could be utilized for both cancer therapy and BTE. Such serviceable BCR SCF offer a lot of promise in terms of fixing surgically produced bone defects and killing any remaining tumor cells in order to attain bone tumor treatment. Lastly, a quick assessment of forthcoming developments in this topic is presented (). Bones, like natural nanocomposites in the human body, have multi-layer architectures with complicated compositions, as seen in Figure 1.
FIGURE 1
3-Dimensional Printing Manufacturing Techniques Benefits
Traditional fabrication procedures such as gas flocculation, fibre bonding, freeze dryness, phases isolation, and particle rinsing were used to create most SCF at first (
The advantages of fabricating bio-ceramic SCF using the 3DP approach are as follows: 1) SCF’ inner and exterior architectures, such as pore form, perviousness, and interconnectedness, could be precisely manipulated to achieve extraordinary organizational complication, elasticity, and patient-particular burdens (
Benefits of 3-Dimensional Printing-B Scaffolds
Owing to their resemblance to the synthetic formulation, impact strength, wettability, bioactivity, bio - compatibility, osteoconductivity, and possible osteoinduction of the bone, bio-ceramics have become the subject of intense research for years (
The use of mesoporous bioactive glasses (MBGs) to fabricate scaffolds via 3D printing has been identified as having significant promise for the creation of bioactive synthetic bone replacements. The obvious advantages of additive manufacturing make it an attractive strategy for circumventing the most common limitations of traditional fabrication processes for glass and ceramic scaffolds, such as poor reproducibility and control over the final 3D structure, as well as low mechanical strength. Additionally, the highly tailorable textural characteristics of mesoporous materials were discovered to be critical in the construction of multifunctional systems capable of concurrently supporting bone repair and therapeutic action via local delivery of medicines and/or biologically active ions (
TABLE 1
| Material | Binding agent | Mesopore SDA | BET surface area (m2/g) | Dispensing pressure (kPa) | Size (µm) | Reference |
| SiO2-CaO-P2O5 MBG/PCL composite | poly(caprolactone) | F-127 | 520 | Not reported | 190 | |
| SiO2-P2O5 MBG | methyl cellulose | F-127 | 152–310 | Adapted during printing | 400 | |
| CSH/SiO2-CaO-P2O5 MBG | poly(caprolactone) | P123 | 4.5–12.8 | 220–360 | 350 | |
| Carboxylic-modified SiO2-CaO-P2O5 MBG | poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) | P123 | 63–330 | Not reported | 250 | |
| SiO2-CaO-P2O5 MBG/alginate composite | Alginate | P123 | Not reported | 180–250 | 344–415 |
Selected studies using 3D-printed mesoporous bioactive glasses material, their parameters, manufacturing and other structural details.
3-Dimensional Printing-B Scafflold for Biomedical Applications Together in Variety of Components
Bio-ceramics for bone tissue manufacturing include Ca-PHPH ceramics, CS ceramics, and BGs, among others. The utilisation of 3DP-B SCF in BTRis determined by their printable, mechanical, and biological characteristics. Lewis et al. have published numerous papers on the construction of complicated 3D-printed SCF with improved performance. They also gave a thorough overview of the various characteristics and parameters of 3DP methods on ceramic constructions.
Calcium-(poly (3-hydroxybutyrate- co-3-hydroxyhexanoate) Bioceramic Scaffold
Different reports have been revealed that some Ca-PHPH (poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) ceramics are osteoinductive in the absent of supplementation (
Hydroxyapatite (HA) is a kind of calcium PHPH. HA (Ca10(PO4)6(OH)2) is an utmost studied Ca PHPH bio-ceramics in bone tissues engineering based on the chemical arrangement, which is comparable to that of the primary bone components, resulting in beneficial effects on osteoblast adhesion and proliferation (
Tricalcium PHPH (TCP) is another typical Ca-PHPH ceramic, because to its quick breakdown degree and capability to establish a strong bone–calcium PHPH connection. Certain biomimetic implants, including HA, have indeed been proven to deteriorate more rapidly as TCP ceramics. Porosity, stiffness, and tenacity (the min particle size and parting space of the struts, that could be exactly regulated by a 3DP) of 3DP TCP-SCF are all influenced by particle diameter, depowering effectiveness, adhesive droplet size, and scaffolding shape (
Calcium-Silicon Bioceramic Scaffold
CS (CaSiO3) ceramics, a form of unique bioactive substance, have been inspected for bone regeneration (
Bioactive Glasses
Hench was the one who discovered BGs. Na2O, CaO, SiO2, and P2O5 are the major components of bioactive glasses (BGs). BGs offer a lot of promise in terms of repairing and regenerating bone deficiencies. BGs have osteoconductiveness and oseteoproductiveness, which improves progenitor cell proliferation and differentiation (
Different Doped Elements
Biotic apatite’s, a chemical component of bone, contain a definite quantity of Zn++, Sr++, Mn++, and Mg++ in addition to HA. These ions have their own roles, and by gently releasing these therapeutic ions, they stimulate osteogenesis and angiogenesis.
The integration of Zn++ in HA ceramics increases the dissociation property, encourages osteoblastic activity from bone marrow stromal cells in vitro, and obviously boosts new bone formation in vivo (
Manganese (Mn), an abundant mineral component for regular human metabolism (e.g., biosynthesis in bone tissues), has many benefits as a dopant factor for tissue engineering (
Phosphocalcic Cement
Historically, Legeros et al. (1982) was the first to suggest biomaterial phosphocalcic cement. Since then a range of preparations have been produced, analyzed and commercialized (
TABLE 2
| Name of cement | Manufacturer | Solid-phase composition | Liquid-phase composition | S/L | |
|---|---|---|---|---|---|
| α—BSM (Biobon, Embarc) | ETEX | ACP + DCPD | Physiological serum | 0.67 (g/cm3) | |
| VitalOs | CalciOS | 1: βTCP + Na 2H2P2O7 | 1: water | ||
| 2: MCPM + CaSO 4, 2H2O | 2: water + H3PO4 | ||||
| Eurobone | Kasios | βTCP + Na4P2O7 | water + H2SO4 | ||
| Bonesource | Stryker—Leibinger Corporation | TTCP + DCPA | Na | 0.25 (g/cm3) | |
| 2HPO4 + | |||||
| NaH | |||||
| 2PO4 | |||||
| Calcibon | Biomet | αTCP + DCPA + CaCO3 + PHA | Na2SO4 | ||
| ChronOS Synthes | βTCP + MCPM + MgHPO4 + MgSO4 | Na2H2P2O7 Hyaluronate de Sodium | |||
| Cerapaste (Primafix) | NGK Spark Plug | TTCP + DCPA | Sodium |
Examples of commercially available phosphocalcic cements (
3-DPrinting-BScaffold With Varied Macro/Microstructures for Bone Tissue Engineering
Among the most challenging problems encountered in area of biomedical applications is the fabrication of hierarchical porous SCF that imitate the conformational shape and features of actual bone. To demonstrate features, nutrition delivery, and cell–matrix interactions, the architecture must be developed at the macros, micros, and nanos dimensions (Figure 2). Macrostructure is important in BTE because it is closely linked to the degree of bone ingrowth. Porous structure, pore diameter, pore shape, and pore interconnectivity, in particularly, have a significant influence on scaffold function, cell penetration, and adhesion to scaffold macropores, all of which play a role in osseointegration.
FIGURE 2

The impact of hollow tubes on the delivery of stem cells. (A) Scanning electron microscope images of adhering rBMSCs on the scaffold surface. In the hollow channels of the BRT-H scaffolds, cells may be seen. (B) After 7 days of in vitro cultivation, the cells in the hollow channels were still alive. (C) Cell viability of rBMSCs planted in scaffolds on day 1 and day 7. (D) Mice were implanted with scaffolds containing luciferase-labeled BMSCs, which were identified using in vivo fluorescence imaging. (E) Relative fluorescence intensity statistical findings. Reproduced with permission from (
The Influence of Macrostructure on Physico-chemical Assets
BCR SCF are being reported extensively in bone regeneration due to their resemblence to bone inorganic compounds, bioactivity, bio - compatibility, osteoinduction, and probable osteoinductivity. Nevertheless, in a number of cases, their mechanical properties limited their application. As a consequence, scientists attempted to modify the porosities of BCR SCF to generate mechanical properties which suited the requirements of the ultimate implementation. Roohani-Esfahani et al. developed Sr-HT Gahnite, a BG ceramic with a novel triphasic microstructure comprising of strontium (Sr)-doped hardystonite (Ca2ZnSi2O7, HT) grains, clustering of submicron gahnite (ZnAl2O4) crystals, and a glass phase. In attempt to construct Sr-HT Gahnite 3DP SCF with improved tensile strength, they employed a range of pore geometrie with a range of porosities (
In comparison to another pore types, SCF with hexagonal designs displayed the peak tensile strength anywhere at particular porosity, leading in a substantially anisotropy morphology and enhanced oad transmission. Because as average diameter grew, the compressive strength of scaffolding with equal pore geometries decreased (450, 550, 900, and 1,200 lm). Sr-HT Gahnite SCF (hexagonal, 50% porosity) have a compressive strength of 180 MPa, demonstrating that they might be utilised to repair load-bearing bone abnormalities (
Influence of Macrostructure on Biological Features
The geometry of macropores can influence cell network creation and tissues implantation (Figure 3) (
FIGURE 3

Tissue development in channels with various cross-sections: triangular, square, hexagonal, and circular. (A) Phalloidin-FITC stained actin stress fibres for various geometries. (B) A computational simulation of tissue development depicting several tissue evolutions. Reproduced with permission from (
Wu et al. employed a customized 3DP methodology to a multichannel structure, that addresses the constraints of the standard 3DP method (
The use of innovative HSP BCR SCF with customized ceramic particles and multioriented hollow channel designs to promote bone regeneration yielded the following findings (
Effect of Micro/nanostructures on Bone Tissue Regeneration
3DP SCF offer greater interconnectedness, ordered crystallinity, and tensile stability than SCF made using conventional techniques, making them appropriate for bone tissue production. Cell leakage from the large hole in 3DP-BSCF is, however, one of their major disadvantages. The creation of hierarchically 3DP-BSCF was detailed in order to imitate the structure of nature. Cell expansions can be provided with anchored sites by the hierarchial porous structure of 3DP SCF, enabling them to multiply as well as permeate the biological material. In addition, the osteogenic activity and bioactivity of hierarchically porous materials is much improved. Several methods for producing hierarchically porous 3DP SCF have been endeavored. The following are a few instances of common questions.
Freeze-Drying Technique
Using 3DP technologies and the thawing process, Xu et al. constructed porous BCR-silk composite SCF with hierarchical pore topologies, that were helpful for osteogenesis. By freeze-drying hierarchial composite SCF, ordered macropores of BCR SCF and micropores of silk networks were produced. The composite SCF have ordered hierarchical pore structures, excellent apatite-mineralization capabilities, and mechanical characteristics with a compressive strength of 25 MPa. The foliage of sheet-shaped polymeric SCF generated mesopores, and the highly porous functions as a net bag to restrict cell leaking from the mesopores of ceramic scaffolding during cell growth. A particular range of enhanced cell density, that is advantageous to cell development, proliferation, and differentiation, aids intercellular interconnections and paracrine communication (
Self-Assembly Method
A hierarchy BCR scaffolding with regulated mesopores and mussel-inspired exterior nanoparticles was produced using a purely self approach (
FIGURE 4

(A) 3D-printed pure bioceramics (BC), DOPA-BC (2 mg/ml), DOPA-BC (4 mg/ml), DOPA-BC (6 mg/ml) scaffolds; (B) Optical photos of pure BC (b) and 4 mg/ml DOPA-BC (C) scaffolds on top view; (G) SEM images of pure BC (D) and 2 mg/ml DOPA-BC (E), 4 mg/ml. Reproduced with permission from (
Spin Coating Technique
Zhang et al. created MBG-modified b-TCP SCF with a functioning MBG nanolayer and a hierarchy pore structure evenly covered on the scaffolding columns using 3DP and spin coating methods (
Hydration Process
A innovative scaffolding incorporating calcium sulphate hemihydrate (CSH) and highly porous calcium Si (MCS) for BTEwas formed utilizing 3DP and hydration processes, with CSH illustrating functionality in raising compressive strength, prohibiting rapid pH increases, and balancing biodegradation. Moreover, the MCS component may load dexamethasone into particular regions and release it at a slow rate. BTE might benefit from the SCF (
Nano-Stereolithography
“Cha et al. utilized the nanostereolithography (NSTL) technology to integrate micro patterns on the scaffolding. They examined the effects of micropillar and microridge patterns on cell adhesion, proliferation, and osteogenic differentiation on 3Dprinted SCF. They observed that SCF with micropatterns seemed to improve cell adherence when compared to non-patterned SCF. Investigators also perceived that bone-related gene expression, such as Runx2 and ALP, was much greater in micro patterns (micro-pillar and micro-ridge) than in non-patterned SCF(
3-Dimensional Printing-B Scaffold for Bone Tumor Therapy
A significant integer of 3DP-BSCF with predetermined configuration and construction have been created and shown to have good physicochemical and biotic presentation, suggesting that they might be used in BTE. In addition to its use in bone tissue engineering, new functional BCR SCF have been shown to have the capacity to treat tumors and regenerate bone tissue at the same time. As a result, these practical SCF may be used to mend bone defects caused by surgery while also killing any remaining tumor cells, achieving the goal of bone tumor treatment (Figure 5). Unlike chemo/radiotherapy, photothermal/magnetothermal therapy has minimal adverse effects and may selectively and efficiently ablate tumor cells without harming healthy tissue. Permanent proteomic degradation, cellular membranes degradation, and delayed advanced apoptosis are all caused by high temperatures generated by functional SCF. As a result, photothermal or magnetothermal agents can be used locally with functional SCF that have good photothermal or magnetothermal performance. Furthermore, these functional BCR SCF have good biocompatibility, encourage bone MSC migration, attachment, proliferation, and differentiation, and indorse fresh bone creation in vivo. Some researchers have recently concentrated on the development of such functional 3DP SCF for use in bone tumour treatment.
FIGURE 5

Bifunctional scaffold with nanolayer developed with 3D Printing and dopamine modification. Reproduced with permission from (
GZ-modified BCR scaffolding with good photothermic upshot was created by Wu et al. (
CuFeSe2 nanocrystals may develop in situ on the strut surface of BG SCF using the solvothermal reaction technique, resulting in tight interactions between CuFeSe2 nanocrystals and BG SCF (Figure 6). The narrow energy band of CuFeSe2 (0.16 eV) was attributed to the good photothermal effect of bifunctional SCF, leading in effective light absorption. The released Ca, Si, P, Fe, Cu, and Se ions may work synergistically to induce rabbit bone MSC osteogenesis. A new bifunctional scaffolding containing CuFeSe2 nanocrystals might be used as a therapeutic treatment approach for tumor-induced bone abnormalities (
FIGURE 6

Illustration showing (A) CuFeSe2 nanocrystals on BG scaffolds and (B) their bifunction of bone tumor therapy and tissue regeneration. Reproduced with permission from (
Elements doped BG-ceramic (BGC) SCF demonstrated photothermal effect and osteogenic differentiation capacity utilizing the 3DP technique. The photothermal effect followed this pattern: 5Cu-BGC is superior. The produced high temperature was efficient in killing tumour cells and inhibiting tumor growth in vivo due to the photothermal impact of 5Cu-BGC, 5Fe-BGC, and 5Mn-BGC SCF. Furthermore, the ionic products produced by element-doped SCF appeared to stimulate the osteogenic differentiation of bone-forming cells, and 5Fe-BGC and 5Mn-BGC SCF enhanced the affection of rabbit bone MSCs. The effect of 5Co-BGC SCF on ALP expression was substantially greater than the effect of other SCF. Furthermore, as compared to a blank control, element-doped SCF clearly enhanced VEGF expression in rabbit bone MSCs. According to the findings, 5Fe-BGC and 5Mn-BGC SCF might be used in the photothermal therapy of bone tumors and BTR (
Synergy aimed photothermal and reactive oxygen species (ROS) treatments outperformed solo photothermal therapy in terms of tumor therapeutic efficacy. 3DP was used by Wu et al. to construct CaSiO3-Fe complex SCF (
Magnetothermal treatment, photothermal therapy, can be used to destroy tumor cells using functional magnetic SCF. Because of the success of creating superparamagnetic SCF, an oscillating magnetic field can be used to destroy remaining tumor cells locally. Zhang et al. created a magnetic scaffold using a GO-Fe3O4-GO sandwich layer. With only a few Fe3O4 particles on the surface of the SCF, this sandwich layer had a better magnetothermal effect (Figure 7). Furthermore, the presence of GO is advantageous for heat transmission due to its high thermal conductivity, and for stimulating new bone production (
FIGURE 7

Optical micrographs of b-TCP, b-TCP–4Fe–GO, and b-TCP–8Fe–GO scaffolds (A), b-TCP–4Fe–GO (B), and b-TCP–8Fe–GO scaffolds (C). The fracture surfaces of b-TCP–GO (D), b-TCP–4Fe–GO (E), and b-TCP–8Fe–GO (F) scaffolds revealed sandwich-like layers in the magnetic scaffolds.
Patients may develop bacterial infections when using implanted materials, posing a significant danger. Zhang et al. created silver (Ag)/GO particle-modified b-TCP BCR SCF called Ag@GO. The inclusion of Ag ion in the SCF resulted in significant antibacterial activity. GO has a number of beneficial characteristics, including conductivity, biocompatibility, and excellent mechanical properties. They focused on its capacity to boost BMSC angiogenesis and mass formation in this investigation (
Conclusion
“In conclusion, when it comes to realizing extraordinary organizational complication, adaptability, and patient-specific needs, 3DP technology clearly outperforms older approaches. In terms of content and hierarchical structure, this study detailed the progress of 3DP-BSCF for presentations ranges from BTE to bone cancer management (macros, micros, and nanos levels). We focused on the impact of scaffold composition and hierarchical structure on physical, chemical, and biological characteristics. 3DP SCF have a hierarchical structure that can provide anchoring sites for cell expansions, promote cell spread, and further govern cell network development and tissue ingrowth. We described certain bi-functional BCR SCF in particular that have good photothermal or antibacterial performance while also promoting bone tissue regeneration. Such bi-functional BCR SCF provide up new avenues for the treatment of bone tumors. Surely, the current 3DP technology has certain drawbacks in terms of additional needs. Processability and regenerability are critical in tissue engineering, and factors including mechanical properties, degradation rate, and scaffold precision must be continually improved. As a result, 3DP technology’s precision and digital operating system must be continually enhanced. In the future, better spatial resolution than the current resolution given by main 3DP methods will be required to create 3DP ceramic SCF that mimic the natural macros, micros, and nanos structures of the bone.”
“To avoid powdered particle aggregation, one option is to utilize powdered granules with excellent flowability and an appropriate binder solution. Furthermore, as an emerging technology, a high-performance 3DP will be costly. To cut costs, greater technical innovation and multidisciplinary collaboration are required. 3DP SCF for BTR still require post-treatments like high-temperature sintering or densification. The shrinking of various portions of the SCF during the sintering process may be uneven, causing the SCF to fracture and become useless. The micropore and microstructure of 3DP SCF generated by 3DP cannot be smaller than 10 lm due to resolution limitations. Nanomaterials are integrated into 3DP inks or changed on the surface of 3DP-BSCF to create microstructures. Furthermore, the sintering procedure has a significant impact on the BCR SCF′ microporosity. During the sintering process, the binder will be removed from the SCF, revealing the micropores. The microporosity of sintered SCF is determined by the binder concentration. In the case of bone tumour therapy, a compelling big animal model is required to test the bi-functional BCR SCF’ potential to be utilized for both bone tumor therapy and BTR in the same animal. The following are thought to be the key issues and obstacles in the development and implementation of 3DP biological tissue-engineered SCF in hospital: 1) the difficulties in controlling the accuracy of 3DP bioactive SCF based on medical individualization needs; 2) the vast differences in mechanical properties between 3DP-B SCF and the clinical requirements of implanted materials under various indication conditions; 3) the difficulty in repairing large bone defects with 3D-printed bioactive SCF under various indication conditions”.
“Biological 3DP technology is a novel approach that has just been introduced to the 3DP sector. This new area, which entails printing tissue-engineered SCF that sustain living cells and even live organs, has a lot of potential. The greatest danger, however, is that the cell structure will be badly disrupted during the printing process. As a result, the major challenge to address during material preparation is maintaining the integrity and activity of the cells before and after printing. It will also be a significant opportunity and challenge to use biological 3DP technology to print certain bi-functional BCR SCF with outstanding photothermal or osteogenic concert. Although current printing methods may generate SCF with structures that are comparable to those of many tissues, completely functional tissue engineered SCF are still a long way off. 3DP tools is an influential inundation that would persist to propel different areas forward. 3DP bioactive SCF will be a great fit for bone abnormalities in the future, and will fulfil clinical individualization criteria. 3DP will be increasingly precise and low-cost as a result of multidisciplinary collaboration and technical progress. Furthermore, some of them will be quite small and portable, and our electronic equipment will be able to manage and reassemble them”.
Statements
Author contributions
ZF, JC, JP, and GL collect the data, wrote the article. CZ design the whole study.
Funding
This work was supported by the Zhejiang Provincial Science and Technology Projects (No. LGF18H180007 to ZXF), Funds of Traditional Chinese Medicine Science and Technology Project of Zhejiang Province (No. 2018ZB131 to ZXF), Zhejiang Provincial Medicine Health Science and Technology Program (2021KY021 to JHC, 2019KY011, 2020KY017 to CZ), and General Project of Zhejiang Provincial Department of Science and Technology (B-2017-J112 to CZ).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
ArmulikA.SvinengG.WennerbergK.FässlerR.JohanssonS. (2000). Expression of Integrin Subunit β1B in Integrin β1-Deficient GD25 Cells Does Not Interfere with αVβ3 Functions. Exp. Cel Res.254 (1), 55–63. 10.1006/excr.1999.4722
2
Asa’adF.PagniG.PilipchukS. P.GiannìA. B.GiannobileW. V.RasperiniG. (2016). 3D-Printed Scaffolds and Biomaterials: Review of Alveolar Bone Augmentation and Periodontal Regeneration Applications. Int. J. Dentistry2016, 1239842. 10.1155/2016/1239842
3
BainoF.FiumeE. (2020). 3D Printing of Hierarchical Scaffolds Based on Mesoporous Bioactive Glasses (MBGs)-Fundamentals and Applications. Materials13 (7), 1688. 10.3390/ma13071688
4
BohnerM.van LentheG. H.GrünenfelderS.HirsigerW.EvisonR.MüllerR. (2005). Synthesis and Characterization of Porous β-tricalcium Phosphate Blocks. Biomaterials26 (31), 6099–6105. 10.1016/j.biomaterials.2005.03.026
5
BoseS.VahabzadehS.BandyopadhyayA. (2013). Bone Tissue Engineering Using 3D Printing. Mater. Today16 (12), 496–504. 10.1016/j.mattod.2013.11.017
6
BrunelloG.SivolellaS.MeneghelloR.FerroniL.GardinC.PiattelliA.et al (2016). Powder-based 3D Printing for Bone Tissue Engineering. Biotechnol. Adv.34 (5), 740–753. 10.1016/j.biotechadv.2016.03.009
7
ButscherA.BohnerM.HofmannS.GaucklerL.MüllerR. (2011). Structural and Material Approaches to Bone Tissue Engineering in Powder-Based Three-Dimensional Printing. Acta Biomater.7 (3), 907–920. 10.1016/j.actbio.2010.09.039
8
BădilăA. E.RădulescuD. M.NiculescuA. G.GrumezescuA. M.RădulescuM.RădulescuA. R. (2021). Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-To-Date Review. Cancers (Basel)13 (16), 4229. 10.3390/cancers13164229
9
CaoH.KuboyamaN. (2010). A Biodegradable Porous Composite Scaffold of PGA/β-TCP for Bone Tissue Engineering. Bone46 (2), 386–395. 10.1016/j.bone.2009.09.031
10
ChaH.-S.KimK.-H.KoY.-J. (2012). Selecting Optimum Management Practicesin Pre-construction Phase Considering Project Characteristics. J. Construction Eng. Project Management2 (1), 1–4. 10.6106/jcepm.2012.2.1.001
11
DangW.LiT.LiB.MaH.ZhaiD.WangX.et al (2018). A Bifunctional Scaffold with CuFeSe2 Nanocrystals for Tumor Therapy and Bone Reconstruction. Biomaterials160, 92–106. 10.1016/j.biomaterials.2017.11.020
12
De Aza, Luklinska, Martinez, Anseau, Guitian, and De Aza (2000). Morphological and Structural Study of Pseudowollastonite Implants in Bone. J. Microsc.197 (1), 60–67. 10.1046/j.1365-2818.2000.00647.x
13
EliazN.MetokiN. (2017). Calcium Phosphate Bioceramics: a Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications. Materials10 (4), 334. 10.3390/ma10040334
14
FengC.ZhangW.DengC.LiG.ChangJ.ZhangZ.et al (2017). 3D Printing of Lotus Root-like Biomimetic Materials for Cell Delivery and Tissue Regeneration. Adv. Sci.4 (12), 1700401. 10.1002/advs.201700401
15
GarcíaA.Izquierdo-BarbaI.ColillaM.de LaordenC. L.Vallet-RegíM. (2011). Preparation of 3-D Scaffolds in the SiO2-P2o5 System with Tailored Hierarchical Meso-Macroporosity. Acta Biomater.7 (3), 1265–1273. 10.1016/j.actbio.2010.10.006
16
GariboldiM. I.BestS. M. (2015). Effect of Ceramic Scaffold Architectural Parameters on Biological Response. Front. Bioeng. Biotechnol.3, 151. 10.3389/fbioe.2015.00151
17
GuvendirenM.MoldeJ.SoaresR. M. D.KohnJ. (2016). Designing Biomaterials for 3D Printing. ACS Biomater. Sci. Eng.2 (10), 1679–1693. 10.1021/acsbiomaterials.6b00121
18
HaoZ.SongZ.HuangJ.HuangK.PanettaA.GuZ.et al (2017). The Scaffold Microenvironment for Stem Cell Based Bone Tissue Engineering. Biomater. Sci.5 (8), 1382–1392. 10.1039/c7bm00146k
19
HwaL. C.RajooS.NoorA. M.AhmadN.UdayM. B. (2017). Recent Advances in 3D Printing of Porous Ceramics: A Review. Curr. Opin. Solid State. Mater. Sci.21 (6), 323–347. 10.1016/j.cossms.2017.08.002
20
InagakiM.KameyamaT. (2007). Phase Transformation of Plasma-Sprayed Hydroxyapatite Coating with Preferred Crystalline Orientation. Biomaterials28 (19), 2923–2931. 10.1016/j.biomaterials.2007.03.008
21
InzanaJ. A.OlveraD.FullerS. M.KellyJ. P.GraeveO. A.SchwarzE. M.et al (2014). 3D Printing of Composite Calcium Phosphate and Collagen Scaffolds for Bone Regeneration. Biomaterials35 (13), 4026–4034. 10.1016/j.biomaterials.2014.01.064
22
Jin WooL.Dong-WooC. (2015). 3D Printing Technology over a Drug Delivery for Tissue Engineering. Curr. Pharm. Des.21 (12), 1606–1617.
23
KentleachJ.KaiglerD.WangZ.KrebsbachP.MooneyD. (2006). Coating of VEGF-Releasing Scaffolds with Bioactive Glass for Angiogenesis and Bone Regeneration. Biomaterials27 (17), 3249–3255. 10.1016/j.biomaterials.2006.01.033
24
KokuboT.TakadamaH. (2006). How Useful Is SBF in Predicting In Vivo Bone Bioactivity?Biomaterials27 (15), 2907–2915. 10.1016/j.biomaterials.2006.01.017
25
KumarA.KargozarS.BainoF.HanS. S. (2019). Additive Manufacturing Methods for Producing Hydroxyapatite and Hydroxyapatite-Based Composite Scaffolds: A Review. Front. Mater.6, 313. 10.3389/fmats.2019.00313
26
LaiY.CaoH.WangX.ChenS.ZhangM.WangN.et al (2018). Porous Composite Scaffold Incorporating Osteogenic Phytomolecule Icariin for Promoting Skeletal Regeneration in Challenging Osteonecrotic Bone in Rabbits. Biomaterials153, 1–13. 10.1016/j.biomaterials.2017.10.025
27
LeeB.-T.KimK.-H.YounH.-C.SongH.-Y. (2007). Functionally Gradient and Micro-channeled Al2O3?(t-ZrO2)/HAp Composites. J. Am. Ceram. Soc.90 (2), 629–631. 10.1111/j.1551-2916.2006.01394.x
28
LiX.LiuW.SunL.AifantisK. E.YuB.FanY.et al (2014). Resin Composites Reinforced by Nanoscaled Fibers or Tubes for Dental Regeneration. Biomed. Res. Int.2014, 542958. 10.1155/2014/542958
29
LiX.FengQ. (2005). Porous Poly-L-Lactic Acid Scaffold Reinforced by Chitin Fibers. Polym. Bull.54 (1), 47–55. 10.1007/s00289-005-0364-7
30
LiX.SogoY.ItoA.MutsuzakiH.OchiaiN.KobayashiT.et al (2009). The Optimum Zinc Content in Set Calcium Phosphate Cement for Promoting Bone Formation In Vivo. Mater. Sci. Eng. C.29 (3), 969–975. 10.1016/j.msec.2008.08.021
31
LiuW.-J.TianK.JiangH.ZhangX.-S.YangG.-X. (2013). Preparation of Liquid Chemical Feedstocks by Co-pyrolysis of Electronic Waste and Biomass without Formation of Polybrominated Dibenzo-P-Dioxins. Bioresour. Technology128, 1–7. 10.1016/j.biortech.2012.10.160
32
LiuY.LiT.MaH.ZhaiD.DengC.WangJ.et al (2018). 3D-printed Scaffolds with Bioactive Elements-Induced Photothermal Effect for Bone Tumor Therapy. Acta Biomater.73, 531–546. 10.1016/j.actbio.2018.04.014
33
LuD.LiuY.LiW.MaH.LiT.MaX.et al (2021). Development and Application of 3D Bioprinted Scaffolds Supporting Induced Pluripotent Stem Cells. Biomed. Res. Int.2021, 4910816. 10.1155/2021/4910816
34
LuJ.DescampsM.DejouJ.KoubiG.HardouinP.LemaitreJ.et al (2002). The Biodegradation Mechanism of Calcium Phosphate Biomaterials in Bone. J. Biomed. Mater. Res.63 (4), 408–412. 10.1002/jbm.10259
35
LuoY.WuC.LodeA.GelinskyM. (2013). Hierarchical Mesoporous Bioactive Glass/alginate Composite Scaffolds Fabricated by Three-Dimensional Plotting for Bone Tissue Engineering. Biofabrication5 (1), 015005.
36
LuoY.WuC.LodeA.GelinskyM. (2012). Hierarchical Mesoporous Bioactive Glass/alginate Composite Scaffolds Fabricated by Three-Dimensional Plotting for Bone Tissue Engineering. Biofabrication5 (1), 015005. 10.1088/1758-5082/5/1/015005
37
LuoY.ZhaiD.HuanZ.ZhuH.XiaL.ChangJ.et al (2015). Three-Dimensional Printing of Hollow-Struts-Packed Bioceramic Scaffolds for Bone Regeneration. ACS Appl. Mater. Inter.7 (43), 24377–24383. 10.1021/acsami.5b08911
38
MaH.JiangC.ZhaiD.LuoY.ChenY.LvF.et al (2016). A Bifunctional Biomaterial with Photothermal Effect for Tumor Therapy and Bone Regeneration. Adv. Funct. Mater.26 (8), 1197–1208. 10.1002/adfm.201504142
39
MaH.LuoJ.SunZ.XiaL.ShiM.LiuM.et al (2016). 3D Printing of Biomaterials with Mussel-Inspired Nanostructures for Tumor Therapy and Tissue Regeneration. Biomaterials111, 138–148. 10.1016/j.biomaterials.2016.10.005
40
MarquesC. F.OlheroS.AbrantesJ. C. C.MaroteA.FerreiraS.VieiraS. I.et al (2017). Biocompatibility and Antimicrobial Activity of Biphasic Calcium Phosphate Powders Doped with Metal Ions for Regenerative Medicine. Ceramics Int.43 (17), 15719–15728. 10.1016/j.ceramint.2017.08.133
41
MathieuL.MuellerT.BourbanP.PiolettiD.MullerR.MansonJ. (2006). Architecture and Properties of Anisotropic Polymer Composite Scaffolds for Bone Tissue Engineering. Biomaterials27 (6), 905–916. 10.1016/j.biomaterials.2005.07.015
42
MestresG.GinebraM.-P. (2011). Novel Magnesium Phosphate Cements with High Early Strength and Antibacterial Properties. Acta Biomater.7 (4), 1853–1861. 10.1016/j.actbio.2010.12.008
43
MirtchiA. A.LemaitreJ.TeraoN. (1989). Calcium Phosphate Cements: Study of the β-tricalcium Phosphate - Monocalcium Phosphate System. Biomaterials10 (7), 475–480. 10.1016/0142-9612(89)90089-6
44
MondalS.HaldarS.SahaP.GhoshT. K. (2010). Metabolism and Tissue Distribution of Trace Elements in Broiler Chickens' Fed Diets Containing Deficient and Plethoric Levels of Copper, Manganese, and Zinc. Biol. Trace Elem. Res.137 (2), 190–205. 10.1007/s12011-009-8570-z
45
MonmaH. (1988). Preparation and Properties of Porous Apatite by the Hydration Adn Hardening Method. Gypsum Lime212, 25–28.
46
NiS.LinK.ChangJ.ChouL. (2008). β-CaSiO3/β-Ca3(PO4)2 Composite Materials for Hard Tissue Repair:In Vitro Studies. J. Biomed. Mater. Res.85A (1), 72–82. 10.1002/jbm.a.31390
47
NowickiM.CastroN. J.RaoR.PlesniakM.ZhangL. G. (2017). Integrating Three-Dimensional Printing and Nanotechnology for Musculoskeletal Regeneration. Nanotechnology28 (38), 382001. 10.1088/1361-6528/aa8351
48
ParkJ.BauerS.von der MarkK.SchmukiP. (2007). Nanosize and Vitality: TiO2 Nanotube Diameter Directs Cell Fate. Nano Lett.7 (6), 1686–1691. 10.1021/nl070678d
49
PeiP.WeiD.ZhuM.DuX.ZhuY. (2017). The Effect of Calcium Sulfate Incorporation on Physiochemical and Biological Properties of 3D-Printed Mesoporous Calcium Silicate Cement Scaffolds. Microporous Mesoporous Mater.241, 11–20. 10.1016/j.micromeso.2016.11.031
50
PhamD. T.GaultR. S. (1998). A Comparison of Rapid Prototyping Technologies. Int. J. Machine Tools Manufacture38 (10), 1257–1287. 10.1016/s0890-6955(97)00137-5
51
QiX.PeiP.ZhuM.DuX.XinC.ZhaoS.et al (2017). Three Dimensional Printing of Calcium Sulfate and Mesoporous Bioactive Glass Scaffolds for Improving Bone Regeneration In Vitro and In Vivo. Sci. Rep.7, 42556. 10.1038/srep42556
52
RainerA.GiannitelliS. M.AbbruzzeseF.TraversaE.LicocciaS.TrombettaM. (2008). Fabrication of Bioactive Glass-Ceramic Foams Mimicking Human Bone Portions for Regenerative Medicine. Acta Biomater.4 (2), 362–369. 10.1016/j.actbio.2007.08.007
53
Rapacz-KmitaA.ŚlósarczykA.PaszkiewiczZ. (2006). Mechanical Properties of HAp-ZrO2 Composites. J. Eur. Ceram. Soc.26 (8), 1481–1488. 10.1016/j.jeurceramsoc.2005.01.059
54
Roohani-EsfahaniS. I.NewmanP.ZreiqatH. (2016). Design and Fabrication of 3D Printed Scaffolds with a Mechanical Strength Comparable to Cortical Bone to Repair Large Bone Defects. Sci. Rep.6 (1), 19468. 10.1038/srep19468
55
RyuH.-S.HongK. S.LeeJ.-K.KimD. J.LeeJ. H.ChangB.-S.et al (2004). Magnesia-doped HA/β-TCP Ceramics and Evaluation of Their Biocompatibility. Biomaterials25 (3), 393–401. 10.1016/s0142-9612(03)00538-6
56
SalinasA. J.EsbritP.Vallet-RegíM. (2013). A Tissue Engineering Approach Based on the Use of Bioceramics for Bone Repair. Biomater. Sci.1 (1), 40–51. 10.1039/c2bm00071g
57
SamavediS.WhittingtonA. R.GoldsteinA. S. (2013). Calcium Phosphate Ceramics in Bone Tissue Engineering: A Review of Properties and Their Influence on Cell Behavior. Acta Biomater.9 (9), 8037–8045. 10.1016/j.actbio.2013.06.014
58
SantosM. I.ReisR. L. (2010). Vascularization in Bone Tissue Engineering: Physiology, Current Strategies, Major Hurdles and Future Challenges. Macromol. Biosci.10 (1), 12–27. 10.1002/mabi.200900107
59
SrivastavaA. K.PyareR.SinghS. P. (2012). In Vitro Bioactivity and Physical-Mechanical Properties of MnO2 Substituted 45S5 Bioactive Glasses and Glass-Ceramics. j biomat tissue engng2 (3), 249–258. 10.1166/jbt.2012.1043
60
SuiB.-D.HuC.-H.LiuA.-Q.ZhengC.-X.XuanK.JinY. (2019). Stem Cell-Based Bone Regeneration in Diseased Microenvironments: Challenges and Solutions. Biomaterials196, 18–30. 10.1016/j.biomaterials.2017.10.046
61
SupingH.BaiyunH.KechaoZ.ZhiyouL. I. (2004). Effects of Coatings on the Mechanical Properties of Carbon Fiber Reinforced HAP Composites. Mater. Lett.58 (27), 3582–3585. 10.1016/j.matlet.2004.05.086
62
SuwanprateebJ.SanngamR.SuvannaprukW.PanyathanmapornT. (2009). Mechanical and In Vitro Performance of Apatite-Wollastonite Glass Ceramic Reinforced Hydroxyapatite Composite Fabricated by 3D-Printing. J. Mater. Sci. Mater. Med.20 (6), 1281–1289. 10.1007/s10856-009-3697-1
63
TamimiF.NihouannenD. L.EimarH.SheikhZ.KomarovaS.BarraletJ. (2012). The Effect of Autoclaving on the Physical and Biological Properties of Dicalcium Phosphate Dihydrate Bioceramics: Brushite vs. Monetite. Acta Biomater.8 (8), 3161–3169. 10.1016/j.actbio.2012.04.025
64
TarafderS.DernellW. S.BandyopadhyayA.BoseS. (2015). SrO‐ and MgO‐doped Microwave Sintered 3D Printed Tricalcium Phosphate Scaffolds: Mechanical Properties and In Vivo Osteogenesis in a Rabbit Model. J. Biomed. Mater. Res.103 (3), 679–690. 10.1002/jbm.b.33239
65
VaeziM.SeitzH.YangS. (2013). A Review on 3D Micro-additive Manufacturing Technologies. Int. J. Adv. Manufacturing Technology67 (5-8), 1721–1754. 10.1007/s00170-012-4605-2
66
WangJ.SunF.SunW.ShiH.YongY.LiuS.et al (2014). Busuishengxue Ranules Mediate Their Effects upon Non-severe Aplastic Anemia via Mitogen-Activated Protein Kinase/extracellular Signal-Regulated Kinase Pathway. J. Traditional Chin. Med.34 (1), 23–29. 10.1016/s0254-6272(14)60049-2
67
WangY.MalcolmD. W.BenoitD. S. W. (2017). Controlled and Sustained Delivery of siRNA/NPs from Hydrogels Expedites Bone Fracture Healing. Biomaterials139, 127–138. 10.1016/j.biomaterials.2017.06.001
68
WinkelA.MeszarosR.ReinschS.MüllerR.TravitzkyN.FeyT.et al (2012). Sintering of 3D-Printed Glass/HAp Composites. J. Am. Ceram. Soc.95 (11), 3387–3393. 10.1111/j.1551-2916.2012.05368.x
69
WoodardJ. R.HilldoreA. J.LanS. K.ParkC. J.MorganA. W.EurellJ. A. C.et al (2007). The Mechanical Properties and Osteoconductivity of Hydroxyapatite Bone Scaffolds with Multi-Scale Porosity. Biomaterials28 (1), 45–54. 10.1016/j.biomaterials.2006.08.021
70
WuS.-C.HsuH.-C.HsuS.-K.WangW.-H.HoW.-F. (2011). Preparation and Characterization of Four Different Compositions of Calcium Phosphate Scaffolds for Bone Tissue Engineering. Mater. Characterization62 (5), 526–534. 10.1016/j.matchar.2011.03.014
71
XuM.LiH.ZhaiD.ChangJ.ChenS.WuC. (2015). Hierarchically Porous Nagelschmidtite Bioceramic-Silk Scaffolds for Bone Tissue Engineering. J. Mater. Chem. B.3 (18), 3799–3809. 10.1039/c5tb00435g
72
XuM.ZhangY.ZhaiD.ChangJ.WuC. (2013). Mussel-inspired Bioactive Ceramics with Improved Bioactivity, Cell Proliferation, Differentiation and Bone-Related Gene Expression of MC3T3 Cells. Biomater. Sci.1 (9), 933–941. 10.1039/c3bm60028a
73
XuS.LinK.WangZ.ChangJ.WangL.LuJ.et al (2008). Reconstruction of Calvarial Defect of Rabbits Using Porous Calcium Silicate Bioactive Ceramics. Biomaterials29 (17), 2588–2596. 10.1016/j.biomaterials.2008.03.013
74
YamadaS.HeymannD.BoulerJ. M.DaculsG. (1997). Osteoclastic Resorption of Calcium Phosphate Ceramics with Different Hydroxyapatite/β-Tricalcium Phosphate Ratios. Biomaterials18 (15), 1037–1041. 10.1016/s0142-9612(97)00036-7
75
YangY.YangS.WangY.YuZ.AoH.ZhangH.et al (2016). Anti-infective Efficacy, Cytocompatibility and Biocompatibility of a 3D-Printed Osteoconductive Composite Scaffold Functionalized with Quaternized Chitosan. Acta Biomater.46, 112–128. 10.1016/j.actbio.2016.09.035
76
YunH.-s.KimS.-e.ParkE. K. (2011). Bioactive Glass-Poly (ε-Caprolactone) Composite Scaffolds with 3 Dimensionally Hierarchical Pore Networks. Mater. Sci. Eng. C.31 (2), 198–205. 10.1016/j.msec.2010.08.020
77
Yves-ChristianH.JanW.WilhelmM.KonradW.ReinhartP. (2010). Net Shaped High Performance Oxide Ceramic Parts by Selective Laser Melting. Phys. Proced.5, 587–594. 10.1016/j.phpro.2010.08.086
78
ZadpoorA. A. (2015). Bone Tissue Regeneration: the Role of Scaffold Geometry. Biomater. Sci.3 (2), 231–245. 10.1039/c4bm00291a
79
ZhangC.-L.HuangT.WuB.-L.HeW.-X.LiuD. (2017). Stem Cells in Cancer Therapy: Opportunities and Challenges. Oncotarget8 (43), 75756–75766. 10.18632/oncotarget.20798
80
ZhangW.FengC.YangG.LiG.DingX.WangS.et al (2017). 3D-printed Scaffolds with Synergistic Effect of Hollow-Pipe Structure and Bioactive Ions for Vascularized Bone Regeneration. Biomaterials135, 85–95. 10.1016/j.biomaterials.2017.05.005
81
ZhangY.ChenH.GuoK.ZhangX.Eben LiS. (2017). Electro-hydraulic Damper for Energy Harvesting Suspension: Modeling, Prototyping and Experimental Validation. Appl. Energ.199, 1–12. 10.1016/j.apenergy.2017.04.085
82
ZhangY.XiaL.ZhaiD.ShiM.LuoY.FengC.et al (2015). Mesoporous Bioactive Glass Nanolayer-Functionalized 3D-Printed Scaffolds for Accelerating Osteogenesis and Angiogenesis. Nanoscale7 (45), 19207–19221. 10.1039/c5nr05421d
83
ZhangY.ZhaiD.XuM.YaoQ.ChangJ.WuC. (2016). 3D-printed Bioceramic Scaffolds with a Fe3O4/graphene Oxide Nanocomposite Interface for Hyperthermia Therapy of Bone Tumor Cells. J. Mater. Chem. B.4 (17), 2874–2886. 10.1039/c6tb00390g
84
ZhaoW.WangJ.ZhaiW.WangZ.ChangJ. (2005). The Self-Setting Properties and In Vitro Bioactivity of Tricalcium Silicate. Biomaterials26 (31), 6113–6121. 10.1016/j.biomaterials.2005.04.025
85
ZhuM.LiK.ZhuY.ZhangJ.YeX. (2015). 3D-printed Hierarchical Scaffold for Localized Isoniazid/rifampin Drug Delivery and Osteoarticular Tuberculosis Therapy. Acta Biomater.16, 145–155. 10.1016/j.actbio.2015.01.034
86
ZhuY.ZhangK.ZhaoR.YeX.ChenX.XiaoZ.et al (2017). Bone Regeneration with Micro/nano Hybrid-Structured Biphasic Calcium Phosphate Bioceramics at Segmental Bone Defect and the Induced Immunoregulation of MSCs. Biomaterials147, 133–144. 10.1016/j.biomaterials.2017.09.018
Summary
Keywords
3D-printed bioceramic scaffolds, bone regeneration, bone tumor, scaffolds, bone
Citation
Fang Z, Chen J, Pan J, Liu G and Zhao C (2021) The Development Tendency of 3D-Printed Bioceramic Scaffolds for Applications Ranging From Bone Tissue Regeneration to Bone Tumor Therapy. Front. Bioeng. Biotechnol. 9:754266. doi: 10.3389/fbioe.2021.754266
Received
06 August 2021
Accepted
04 October 2021
Published
20 December 2021
Volume
9 - 2021
Edited by
Ayşen Tezcaner, Middle East Technical University, Turkey
Updates

Check for updates
Copyright
© 2021 Fang, Chen, Pan, Liu and Zhao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chen Zhao, zhaochen@hmc.edu.cn
† These authors have contributed equally to this work
This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.